Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kaweh Shakery"'
Autor:
Susan E. Bromley, MSc, Kaweh Shakery, MD, Pareen Vora, PhD, Artin Atabaki, PhD, Thomas Reimer, MD, Fellowship in Critical Care, Lawrence McDermott, MD, Fellowships in Pulmonary and Critical Care, Negin Hajizadeh, MD, Fellowships in Medical Informatics, Pulmonary and Critical Care
Publikováno v:
Critical Care Explorations, Vol 6, Iss 9, p e1147 (2024)
OBJECTIVES:. To provide a comprehensive summary of the published data on cause of death in patients with acute respiratory distress syndrome (ARDS). DATA SOURCES:. PubMed (January 2015 to April 2024), bibliographies of relevant articles, and ARDS Net
Externí odkaz:
https://doaj.org/article/c27b7ac9688041c7a3e12de9fcca719b
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Gerald Staedtler,1 Kaweh Shakery,2 Jan Endrikat,3,4 Richard Nkulikiyinka,2 Christoph Gerlinger1,4 1Bayer AG, Pharmaceutical Statistics, 2Bayer AG, Dermatology & Anti-infectives 2, 3Bayer AG, Radiology, Berlin, 4Department of Gynecology, Obstetrics an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668e7105e87375bc5e290aa8b1aa574d
http://europepmc.org/articles/PMC5598547
http://europepmc.org/articles/PMC5598547
Autor:
Ragna Williams, W. Wigger-Alberti, Gerald Staedtler, Yi-Ling von Mackensen, Maciej Hoffman-Wecker, Kaweh Shakery, Richard Nkulikiyinka, Ulrike Grossmann
Publikováno v:
Skin Pharmacology and Physiology. 30:102-114
Background/Aims: Psoriasis plaque tests (PPTs) are important tools in the early phases of antipsoriatic drug development. Two distinct PPT design variants (open vs. occluded drug application) are commonly used, but no previous work has aimed to direc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5a9c8342f53017bb27c424f3d8ea33b
https://doi.org/10.1159/000458415
https://doi.org/10.1159/000458415
Autor:
Stephen, Tyring, James A, Solomon, Gerald, Staedtler, Jason P, Lott, Richard, Nkulikiyinka, Kaweh, Shakery
Publikováno v:
Cutis. 98(4)
Patient-reported treatment outcomes are important for evaluating the impact of drug therapies on patient experience. A randomized, double-blind, vehicle-controlled, parallel-group, multicenter, phase 3 study was conducted in 961 participants to asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f92249ccc7a89e16eba4b0668247c40
https://pubmed.ncbi.nlm.nih.gov/27874885
https://pubmed.ncbi.nlm.nih.gov/27874885
Autor:
James A, Solomon, Stephen, Tyring, Gerald, Staedtler, Meike, Sand, Richard, Nkulikiyinka, Kaweh, Shakery
Publikováno v:
Cutis. 98(3)
Papulopustular rosacea (PPR) is characterized by centrofacial papules and pustules commonly associated with erythema. To compare investigator-reported efficacy outcomes for azelaic acid (AzA) foam 15% versus vehicle foam in PPR, a randomized, vehicle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7cd4a1f641fdf7609b095119ca0b715
https://pubmed.ncbi.nlm.nih.gov/27814413
https://pubmed.ncbi.nlm.nih.gov/27814413
Autor:
Ming-Chun Hsu, Kristian Reich, Richard G. Langley, Ulrich Mrowietz, Y. Wang, Kaweh Shakery, Philippe Szapary
Publikováno v:
Psoriasis Forum. :3-11
Background Ustekinumab has demonstrated significant efficacy and favorable safety in patients with moderate to severe psoriasis. Objective Characterization of patients achieving marked clinical responses (Psoriasis Area and Severity Index [PASI] 90 o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39ca0ce7405be257ec3e3a39c7cbd48b
https://doi.org/10.1177/247553031016a00101
https://doi.org/10.1177/247553031016a00101
Autor:
Zoe Diana, Draelos, Boni E, Elewski, Julie C, Harper, Meike, Sand, Gerald, Staedtler, Richard, Nkulikiyinka, Kaweh, Shakery
Publikováno v:
Cutis. 96(1)
Rosacea is a chronic relapsing skin disorder primarily affecting the face. Although its etiology is not well defined, rosacea is associated with immune dysregulation and inflammation potentiated by external factors. These manifestations lead to skin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fbe26f87d48ebe1e341557919cc78f14
https://pubmed.ncbi.nlm.nih.gov/26244354
https://pubmed.ncbi.nlm.nih.gov/26244354
Publikováno v:
American Journal of Clinical Dermatology. 5:357-359
Glatiramer acetate (copolymer 1, Copaxone®) is a mixture of synthetic polypeptides and is used for the treatment of multiple sclerosis. It has been shown to possess beneficial effects in reducing the relapse rate in relapsing-remitting multiple scle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b560d19c8ec3c4ca8dc56428096aaa47
https://doi.org/10.2165/00128071-200405050-00009
https://doi.org/10.2165/00128071-200405050-00009
Publikováno v:
Klinikleitfaden Dermatologie (Dritte Ausgabe)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aff6a714d69f5a95cc2b5b38e7b3e88f
https://doi.org/10.1016/b978-3-437-22301-3.10014-8
https://doi.org/10.1016/b978-3-437-22301-3.10014-8
Autor:
Thomas Dirschka, Roland Hartwig, Claus Oster-Schmidt, Alexander S. Achenbach, Thorsten Auer, Martina Bacharach-Buhles, Joachim Barth, Erhard Bierhoff, Jörg Braun, Angeliki Chrissafidou, Aletta Eberlein, Claudia El Gammal, Stephan El Gammal, Steffen Emmert, Wilma Fischer-Barth, Regina Fölster-Holst, Marcus Freitag, Uwe Gieler, Regine Gläser, Norbert Haake, Axel Hauschild, Max Hundeiker, Jochen Jackowski, Katharina Kähler, Wolfgang Kimmig, Gregor von Kobyletzki, Percy Lehmann, Bernhard H. Lenhard, Marion Lubowietzki, Heike Luther, Volker Niemeier, Johannes Niesmann, Claus Nüchel, Ngoc Quan Phan (AÄ), Jörg-Martin Pönnighaus, Peter Radny, Kristian Reich, Uwe Reinhold, Volker Schenkelberger, Kaweh Shakery, Anna Sommer, Sonja Ständer, Wolfram Sterry, Hans-Jürgen Tietz, Hansotto Zaun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecd5b341710269da929e5186933950bd
https://doi.org/10.1016/b978-3-437-22301-3.10033-1
https://doi.org/10.1016/b978-3-437-22301-3.10033-1